# Recipharm and Medspray form joint venture Resyca for softmist nozzles

Recipharm will invest EUR 15 million for a 51% stake in a new joint venture, Resyca BV, with Medspray, which will contribute its softmist spray nozzle intellectual property for pharmaceutical applications. The venture will develop and exploit the technology.

- Type: Partnership
- Announced: 2020-11-19
- Where: Munich, Germany (development facilities); Enschede, Netherlands (nozzle supply), Netherlands
- Value: $17.7M (15.0M EUR)
- Status: announced
- Products: softmist spray nozzles for pharmaceutical inhalation
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Recipharm](https://endata.com/companies/45062.md) (investor)
- [Medspray](https://endata.com/companies/51330.md) (partner)
- [Resyca](https://endata.com/companies/51331.md) (target)

## Sources

- [kennispark.nl](https://kennispark.nl/en/medspray-and-swedish-recipharm-join-forces/), 2020-11-19: "The novel softmist technology represents an opportunity to deliver inhaled therapies in a highly environmentally friendly manner without the need for propellants and less drug being wasted."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.